Renée Fishel

Director of Responsible AI Novartis

Renée Fishel, Director of Responsible AI at Novartis, champions the ethical development and deployment of AI systems across the organization's US commercial functions. Previously, Renée served as a Business Technology Leader and AI Ethics Advocate at IBM, where she conducted in-depth evaluations of high-risk AI use cases, translating complexity into clear, actionable recommendations that guided the AI Ethics Board's approval process. Bringing a rare cross-industry vantage point in AI governance, Renée has navigated both the fast-moving pressures of the tech sector and the heightened regulatory and ethical stakes of pharmaceutical development. This breadth helps drive her belief that principles like fairness, accountability & transparency in AI aren't simply a compliance exercise, but an organizational and cultural commitment that must be embedded at every level. Renée's strong passion for aligning cutting-edge innovation with human-centered values has led her to conducting a number of speaking engagements for the International Institute for Learning (IIL) as well as the European Institute of Innovation for Sustainability (EIIS) on AI ethics.